Anthropic IPO date price and how to buy ANT stock — that is the search bringing half of Wall Street to Google this week, so here is the short answer first. Anthropic, the company behind the Claude AI models, is expected to set its IPO price tonight, Wednesday, November 18, and start trading Thursday, November 19, on the Nasdaq under the ticker ANT. The filed price range is $70 to $78 a share. Everything after that sentence is the fine print, and with this deal, the fine print is where the money is.
This is not a normal IPO. At the top of the range it would be the largest American listing ever attempted, raising up to about $64.35 billion from the public offering alone, with another $26 billion coming in alongside it from seven of the biggest technology companies on earth. The valuation talk runs from about $1 trillion to $1.6 trillion depending on how you count the shares, which is exactly why you keep seeing different numbers in different headlines. We will sort that out below, in plain English.
One thing before we go further: the dates are expected, not final. The company says pricing is expected November 18 and trading November 19, subject to regulatory clearance. The order book closed Tuesday afternoon at 4 p.m. Eastern, and by Tuesday evening CNBC's David Faber was reporting, citing multiple sources, that the deal is likely to price above the filed range. The Wall Street Journal went further, reporting the price could come in above $80. So treat $70 to $78 as the starting point of the conversation, not the final word.
What the deal actually is
Anthropic is selling 825 million shares of Class A common stock. Of those, 801,351,354 are new shares sold by the company itself, and 23,648,646 are being sold by existing stockholders — and the company gets no money from that second slice. The underwriters, led by Goldman Sachs and Morgan Stanley, have a 30-day option to buy up to another 123,750,000 shares if demand stays hot. That is the standard greenshoe, worth about 15 percent on top of the deal.
The shares will list on the Nasdaq Global Select Market under the symbol ANT, and the prospectus updated on November 17 confirms the listing has been approved. Anthropic is a public benefit corporation, incorporated in Delaware — a detail that matters to its governance story, not to the price you pay on Thursday.
Alongside the public offering, seven companies — Google, Nvidia, AMD, Broadcom, Micron, Microsoft, and TSMC — have agreed to buy $26 billion of non-voting Class N stock at the IPO price in a concurrent private placement. Add that to the public offering and the gross capital coming in approaches $90 billion. Net proceeds to Anthropic are about $84.6 billion after fees and expenses. That is the number to remember if anyone tells you this is a small deal.
The timeline, from confidential draft to trading day
The road here was fast by IPO standards, and the dates tell the story. Anthropic filed a confidential draft registration statement with the SEC on June 1, 2026. The public S-1 followed on October 26. Amendments came on November 2 and November 10, and the roadshow launched the same day the price range was set, November 10. The prospectus was updated again on November 17, confirming the Nasdaq approval and leaving the $70 to $78 range unchanged. The order book closed Tuesday, November 17, at 4 p.m. Eastern. Pricing is expected tonight, Wednesday, November 18. The first trade is expected Thursday, November 19.
Five and a half months from confidential draft to first trade is quick for a deal this size, and it tells you something about the demand. Bankers do not rush a trillion-dollar valuation through the process unless the buyers are already lined up. By November 12, the order book was already about six times oversubscribed, according to Bloomberg, and by Tuesday it had grown to close to seven times the shares on offer, with multiple orders of $10 billion or more. That is the backdrop for everything that follows: this deal is not struggling to find buyers. It is struggling to fit them all in.
The valuation math — why you keep seeing two different trillion-dollar numbers
Here is the confusion, and it is an honest one. At $78 a share, Anthropic is worth about $1.02 trillion on a basic share count. That is the number Reuters and Bloomberg cite. But you will also see "up to about $1.4 trillion," and that number is not wrong either. It is the fully diluted figure.
The difference is simple, even if the numbers are not. The basic count tallies the shares that exist today. The fully diluted count adds the shares that could exist — stock options, equity awards, and other promises that turn into shares over time. The filing lists about 1.77 billion shares under outstanding options, with an average exercise price of $2.91. When a company has handed out that many options at a few dollars a share, the gap between basic and diluted is enormous, and for Anthropic it is roughly $400 billion wide. So when you see $1.02 trillion in one headline and $1.4 trillion in the next, nobody is lying. They are counting different things.
Then the price talk moved. The Wall Street Journal reported the final price may come in above $80, with advisers discussing valuations of $1.5 trillion to $1.6 trillion. CNBC's reporting put the same idea in per-share terms: about $83 a share gets you to $1.5 trillion, about $88 gets you to $1.6 trillion, and the low $80s looked like the strong possibility on Tuesday evening. None of that is filed. The filed range is still $70 to $78. But the books are closed, demand is running at six to seven times the shares on offer, and when demand looks like that, bankers raise the price.
Morningstar, which started coverage on November 12, gave Anthropic a narrow economic moat and a fair value estimate of $92 a share, with a bull case of $188 and a bear case of $25. Read that spread twice. The professionals disagree with each other by more than seven to one. That is not a stock with a settled price. That is a stock with a debate attached.
And one number to get right: if you see $290 billion attached to this IPO, that is wrong. That figure is total global IPO proceeds for the first nine months of 2026, from EY data. It is not Anthropic's deal size, and anyone quoting it as the size of this offering is mixing up two different stories.
The revenue story is genuinely extraordinary
Start with the numbers, because they are the reason this deal exists at all. Anthropic did $41 million of revenue in 2023. Two years later, in 2025, it did $4.6 billion. In the first nine months of 2026 alone it did $33.2 billion — more than ten times the same period a year earlier. The annualized revenue run rate hit about $81 billion as of October 31, up about $10 billion in a single month from the end of September.
The number that made analysts sit up is net revenue retention of about 900 percent. In plain English: the customers Anthropic already had a year ago are now spending roughly nine times as much. That is not a company winning new logos one at a time. That is a company whose existing customers keep buying much, much more — mostly businesses building on Claude, and mostly the coding tools that have become the company's breakout product.
The market noticed before the IPO, too. Back in May, Anthropic raised $65 billion in a Series H round at a $965 billion post-money valuation. That was private money, six months ago, and the public market is now being asked to pay more than that for the same company. Whether that is a bargain or a markup depends entirely on whether you believe the growth rate holds, which brings us to the other side of the ledger.
The $900 billion elephant in the room
No honest article about this IPO can skip the spending. Anthropic's filing discloses about $900.9 billion in aggregate committed spending, mostly for computing power and the infrastructure around it. About $451.6 billion of that comes due before the end of 2030. That is money the company has promised to spend, not money it might spend.
Put that next to the revenue. The business is growing at a speed almost nothing in public markets has ever matched, and it is doing it by renting and building computing capacity at a scale that dwarfs its own revenue. The $26 billion private placement is part of the same picture: the companies selling Anthropic the chips and the cloud capacity are also buying its stock. Google, Nvidia, AMD, Broadcom, Micron, Microsoft, and TSMC are simultaneously suppliers, customers, and shareholders. That alignment is a strength — your biggest suppliers want you to win — and it is also the thing skeptics point at when they ask how much of this growth is real demand and how much is the AI industry buying from itself.
The filing also shows $13.8 billion in remaining performance obligations — contracted revenue that customers have committed to but Anthropic has not delivered yet. That is real backlog, and it is the closest thing to a floor under the growth story. But $13.8 billion of backlog against $900.9 billion of commitments is the ratio to keep in your head. The company has promised to spend far more than it has contracted to take in. It is betting, explicitly, that the revenue keeps compounding faster than the bills.
How a regular investor can actually buy ANT
There are two ways in, and they are not the same thing.
The first is the IPO allocation. Anthropic expects retail investors to get 15 to 20 percent of the shares in the offering — an unusually generous slice, since most big IPOs reserve far less for regular investors. JPMorgan is leading the retail sales effort in the United States, and the filing names six brokerages expected to distribute shares at the IPO price: Charles Schwab, Fidelity, Robinhood, TradePMR, SoFi, and E*Trade. If your broker is one of them, you can usually request shares through the IPO section of the platform. Understand the catch: requesting is not receiving. Allocations can be partial, and with demand running six to seven times the shares on offer, a lot of requests will come back smaller than asked, or empty.
The second way — and the way most regular investors will actually end up buying — is the open market. From Thursday morning, ANT trades like any other stock, and you can buy it through any brokerage account. What you pay is the market price, not the IPO price, and on a hot debut those two numbers can be very far apart within minutes of the open. The opening trade on a deal this size is often chaotic, with wide spreads and fast moves in both directions.
If you decide to buy on day one, a few practical points. Decide your price before the market opens, and use a limit order so you pay no more than that price — a market order in the first minutes of a hot IPO is how people accidentally pay the high of the day. Size the position like a speculation, not a core holding, because that is what it is on day one: a bet on a company with extraordinary growth, an unsettled valuation, and no trading history. And remember the allocation route exists. If you can get shares at the IPO price, that is a better entry than chasing the open, but it is not something you can count on.
The risks, stated plainly
First, the price. The range is $70 to $78, but everything coming out of Tuesday evening says the final price lands above it, with the low $80s the number being discussed. Paying $83 or $85 for a stock whose own filing range topped out at $78 is not a bargain by definition. It is the market telling you demand is enormous. Demand can be right, and it can also be the top.
Second, first-day volatility. Big IPOs routinely swing double-digit percentages on day one, and a stock with no trading history and a trillion-dollar-plus valuation has no anchor. The price can gap up, fade, and gap again before lunch. If you cannot watch that without flinching, day one is not your day.
Third, valuation against profitability. The revenue growth is real — $33.2 billion in nine months is not a promise, it is money already taken in. But growth at this speed is bought with spending commitments of about $900.9 billion, and the company has to keep growing at something close to this pace to justify a trillion-dollar-plus price tag. Morningstar's bear case is $25 a share. Its bull case is $188. That spread is the whole argument in one line: nobody, including the professionals, knows what this company is worth yet.
Fourth, the timetable itself. Pricing tonight and trading Thursday are expected, subject to regulatory clearance. Until the registration is effective and the price is set, the dates can move. They probably will not — the books are closed and the momentum is all one way — but "expected" is doing real work in that sentence, and it is worth reading it literally.
What to watch next
Tonight: the final price. If it lands in the low $80s, the valuation conversation shifts to $1.5 trillion and the question becomes whether the stock can hold it. Thursday: the first trade and the first close. The number that matters is not the opening pop — it is where the stock finishes the day, and whether it holds above the IPO price in the sessions after. Then the quiet part: the first earnings report as a public company, when the market gets to test that $81 billion run rate against audited numbers and real guidance.
The bigger test comes later, and it is the one the whole AI trade is waiting on. Can Anthropic keep growing revenue faster than its compute bill? The filing says the company has committed to spend about $451.6 billion before the end of 2030. The revenue has to chase that number down. If it does, this IPO will look cheap in hindsight at almost any price in the $70s or $80s. If it does not, the valuation math gets very uncomfortable, very fast. That is the bet, and from Thursday morning, anyone with a brokerage account can make it.
Before you act on any of this, do the boring homework. Read the company's own filings, starting with the Anthropic S-1 filings on SEC EDGAR and the prospectus itself. Confirm any broker's background through FINRA BrokerCheck, understand how your account is protected through SIPC, and read the investor-education basics at investor.gov.
Watch the video below for CNBC's Squawk on the Street crew on the roadshow, the price range, and what the deal means as Anthropic heads for public trading.
Watch it here if the embed does not load: Anthropic kicks off IPO roadshow: Here's what you need to know (CNBC, YouTube)
This article is for educational purposes only and is not investment advice. Figures come from Anthropic's S-1 filings on SEC EDGAR and its November 17 prospectus, and from reporting by Reuters, the New York Post, CNBC, Bloomberg, and the Wall Street Journal. Pricing and trading dates are expected, subject to regulatory clearance, and the final IPO price may differ from the filed range. Investing involves risk, including the possible loss of principal. Consider speaking with a qualified financial professional before making investment decisions.

No comments:
Post a Comment